ARSJ
Arylsulfatase J
Also known as: ARSJ_HUMAN, FLJ23548
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5FYB0
- Gene
- ARSJ
- Ensembl
- ENSG00000180801
- Chromosome
- 4
- Canonical length
- 599 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Actin filaments
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Sulfatases (EC 3.1.5.6), such as ARSJ, hydrolyze sulfate esters from sulfated steroids, carbohydrates, proteoglycans, and glycolipids. They are involved in hormone biosynthesis, modulation of cell signaling, and degradation of macromolecules (Sardiello et al., 2005 [PubMed 16174644]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
599 residues, UniProt reviewed canonical sequence.
>Q5FYB0|ARSJ
1 MAPRGCAGHP PPPSPQACVC PGKMLAMGAL AGFWILCLLT YGYLSWGQAL EEEEEGALLA
61 QAGEKLEPST TSTSQPHLIF ILADDQGFRD VGYHGSEIKT PTLDKLAAEG VKLENYYVQP
121 ICTPSRSQFI TGKYQIHTGL QHSIIRPTQP NCLPLDNATL PQKLKEVGYS THMVGKWHLG
181 FYRKECMPTR RGFDTFFGSL LGSGDYYTHY KCDSPGMCGY DLYENDNAAW DYDNGIYSTQ
241 MYTQRVQQIL ASHNPTKPIF LYIAYQAVHS PLQAPGRYFE HYRSIININR RRYAAMLSCL
301 DEAINNVTLA LKTYGFYNNS IIIYSSDNGG QPTAGGSNWP LRGSKGTYWE GGIRAVGFVH
361 SPLLKNKGTV CKELVHITDW YPTLISLAEG QIDEDIQLDG YDIWETISEG LRSPRVDILH
421 NIDPIYTKAK NGSWAAGYGI WNTAIQSAIR VQHWKLLTGN PGYSDWVPPQ SFSNLGPNRW
481 HNERITLSTG KSVWLFNITA DPYERVDLSN RYPGIVKKLL RRLSQFNKTA VPVRYPPKDP
541 RSNPRLNGGV WGPWYKEETK KKKPSKNQAE KKQKKSKKKK KKQQKAVSGS TCHSGVTCGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARSJ can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 5.5 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 5.5 nTPM
- blood vessel: 5.1 nTPM
- cervix: 4.2 nTPM
- placenta: 4 nTPM
- prostate: 3.6 nTPM
- urinary bladder: 3.6 nTPM
Single-cell type
- renal collecting duct intercalated cells: 166 nCPM
- salivary ionocytes: 131 nCPM
- alveolar cells type 1: 110 nCPM
- renal connecting tubule cells: 101 nCPM
- endometrial stromal cells: 85 nCPM
- renal collecting duct principal cells: 84 nCPM
Immune cell
- MAIT T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 11 nTPM
- thalamus: 4.1 nTPM
- basal ganglia: 3.1 nTPM
- cerebral cortex: 2.9 nTPM
- midbrain: 2.6 nTPM
- white matter: 2.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.69
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARSJ as an antibody target. Whether an autoantibody or antibody against ARSJ could matter depends on whether native ARSJ is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARSJ is annotated as secreted, so native ARSJ circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ARSJ as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...